U.S. Online Retail and Ecommerce Stock News

We wouldn't blame Dorman Products, Inc. ( NASDAQ:DORM ) shareholders if they were a little worried about the fact that...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Rave Restaurant Group, Inc. ( NASDAQ:RAVE ) shareholders won't be pleased to see that the share price has had a very...

The SOLAI Limited ( NYSE:SLAI ) share price has fared very poorly over the last month, falling by a substantial 30...

Key Insights The projected fair value for Cerence is US$9.34 based on 2 Stage Free Cash Flow to Equity Cerence's...

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Knightscope, Inc. ( NASDAQ:KSCP ) shareholders won't be pleased to see that the share price has had a very rough month...

Key Insights The considerable ownership by retail investors in ChargePoint Holdings indicates that they collectively...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Editas Medicine, Inc. ( NASDAQ:EDIT ) shares have retraced a considerable 29% in the last month, reversing a fair...

Key Insights JBS' significant private companies ownership suggests that the key decisions are influenced by...

Ever wondered whether Huron Consulting Group is a bargain or priced for perfection? If you are curious about where the stock stands on value right now, you are not alone. Recently, the stock has been anything but quiet, climbing 8.2% this past week, 9.7% over the last month, and delivering a remarkable 33.7% gain year-to-date. These sharp moves have been drawing attention, especially following Huron’s recent announcement of a new strategic partnership and industry accolade. Both of these...

Wondering if Qualys is really worth its current price tag? You are not alone. It pays to dig into what drives the stock’s value before making any decisions. The stock has had a choppy ride lately, down 4.6% over the past week and dropping 12.7% so far this year. This has changed the mood on growth potential and risk. Recent headlines around Qualys have focused on the company's evolving cybersecurity offerings and new partnerships with industry leaders. These developments have attracted...

Xenon Pharmaceuticals (XENE) reported continued unprofitability in its latest quarter and is projected to remain in the red for at least three more years. Over the past five years, losses have grown at an average yearly rate of 37%. However, revenue growth is forecast to accelerate at 72.4% per year, outpacing both the broader US market and the biotech sector. Despite substantial top-line momentum, margins and net profit have yet to improve, keeping earnings quality under pressure. See our...

Greenfire Resources (NYSE:GFR) just posted a dramatic turnaround, with earnings growth reversing from a 20.2% annual decline over the past five years to a staggering 252.7% increase last year. The company’s net profit margin jumped to 19.1% from 5.1% a year ago, while shares now trade at just 3.3x earnings, which is far below the industry average of 12.8x and the peer average of 19.2x. This comes despite a current share price of $4.47 compared to a fair value estimate of $186.11. Momentum has...

Hims & Hers Health (HIMS) posted strong revenue and earnings growth forecasts, with revenue expected to rise 14.7% per year and earnings projected to climb 27.5% annually. Both figures surpass broader US market trends. While the company’s average annual earnings growth reached 62.2% over the past five years, the most recent year saw a 32.1% expansion, and net profit margins dipped to 6.1% compared to 8.2% a year ago. Investors are weighing a solid profitability record and bright growth...

SBA Communications (SBAC) posted net profit margins of 30.7%, rising from 25.8% the previous year, with annual earnings growth averaging 34.2% over the last five years. More recent earnings growth for the past year came in at 25%. Revenue is forecast to grow at just 3% annually, and earnings are expected to increase by 2% per year. Both of these figures trail the broader US market benchmarks. With a Price-To-Earnings ratio of 24.4x, below both its peer average of 30.5x and the industry...

Curious if Four Corners Property Trust is a bargain or too pricey in today’s market? Let’s break down what’s driving the stock’s value and whether there’s opportunity ahead. Even though the stock slipped 0.1% over the past week and 1.8% in the last 30 days, it is only down 9.8% in the past year, showing signs of resilience amidst a tough environment. Investors have been keeping an eye on rising interest rates and evolving commercial real estate trends, both of which continue to influence...

If you have ever wondered whether Vertex stock is trading at a bargain or an inflated price, you are in the right place for some answers. After a rough few months, Vertex shares have dropped by 20.7% over the last week and are down 54.4% over the past year, suggesting a dramatic shift in market sentiment around the company. Much of this decline has been set against a backdrop of challenging headlines, including industry-wide volatility in the software sector, as well as broader market...

Premier (PINC) reported a net profit margin of just 0.7% this quarter, a sharp drop from last year’s 11.2%, with earnings having declined at an average annual rate of -25.5% over the past five years. Despite recent pressures, the company is now profitable and is forecasting a robust 32.6% annual earnings growth over the next three years, which is double the 16% expected for the US market overall. These mixed results, combined with a one-off $162.9 million loss, have pushed Premier’s shares to...

Kura Oncology (KURA) remains unprofitable and is projected to stay in the red for at least the next three years, with losses having widened at a pace of 15.3% per year over the last five. Despite negative profit margins and no signs of bottom-line improvement, the company is forecast to deliver revenue growth of 42.7% annually, significantly outpacing the broader US market’s 10.5% revenue growth expectation. Investors now face a trade-off between robust top-line growth potential and the...

ONE Gas (OGS) reported net profit margins of 10.8%, slightly ahead of last year’s 10.5%, as annual earnings growth reached 17.7%, substantially outpacing the company’s five-year average of 4.5%. Earnings are forecast to grow at 8.94% per year, but both profit and revenue trends remain below broader US market averages. Investors will note that despite stronger bottom-line results, valuation appears mixed given that the stock’s Price-to-Earnings ratio sits between its US and global gas utility...

Harmony Biosciences Holdings (HRMY) delivered a net profit margin of 22.5% this period, well above last year's 18%. Earnings grew by 51.4% over the past year, outpacing both its own five-year average growth rate of 40.8% and broader US market expectations. Looking ahead, analysts forecast earnings to grow 20.5% per year, surpassing the US market's 16%, while revenue is expected to rise at 12.7% annually compared to the market's 10.5% pace. This combination of sustained profitability and...